US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 0.2420
  • -0.0219-8.30%
Close May 3 16:00 ET
  • 0.2404
  • -0.0016-0.66%
Post 17:04 ET
1.47MMarket Cap-576P/E (TTM)

About InMed Pharmaceuticals Company

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It operates through the InMed and BayMedica segments. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Company Profile

SymbolINM
Company NameInMed Pharmaceuticals
Issue Price4.50
Founded1981
CEOMr. Eric A. Adams
MarketNASDAQ
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address815 West Hastings Street,Suite 310
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6C 1B4
Phone1-604-669-7207
Websitehttp://www.inmedpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Eric A. Adams
  • Director, President and Chief Executive Officer
  • 367.57K
  • N. Netta Jagpal
  • Chief Financial Officer, Corporate Secretary and Principal Accounting Officer
  • --
  • Michael Woudenberg
  • Chief Operating Officer
  • 297.42K
  • Alexandra D.J. Mancini
  • Senior Vice President, Clinical and Regulatory Affairs
  • 284.92K
  • Dr. Eric C. Hsu, PhD
  • Senior Vice President, Preclinical Research and Development
  • --
  • Andrew Hull
  • Chairman of the Board
  • 61.10K
  • Nicole Lemerond
  • Independent Director
  • 46.21K
  • Janet Grove
  • Independent Director
  • 48.60K
  • Bryan T. Baldasare
  • Independent Director
  • 48.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg